*** David Sobek is a disciplined value investor.  Using models, research, and fundamental data, David devises a value for biotech stocks, buys when significantly undervalued, and sells when significantly overvalued.***.

You would think replacing a computer would be an easy job, it apparently requires different layers of people and so not everyone was on campus yesterday. So at some point.

The trade war is taking a lot of the headlines and I am running out of time to write as they are replacing my computer soon, which will likely take.

Nothing new to start the week outside of a pretty weak market. I am not sure what the catalyst outside of an extended market but it looks again like the.

EHA is here and there will be some updates that are of interest but for the most part, I do not see it as having a fundamental effect on the.

The sector had a decent day, although participation was not great. We seem to be on the verge of breaking higher (at least in the XBI) but it will be.